OTCMKTS:SHWZ Medicine Man Technologies (SHWZ) Stock Forecast, Price & News $1.03 +0.05 (+4.67%) (As of 06/2/2023 08:49 PM ET) Add Compare Share Share Today's Range$0.97▼$1.0350-Day Range$0.93▼$1.1852-Week Range$0.87▼$2.10Volume53,200 shsAverage Volume43,852 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$3.00 ProfileProfileAnalyst RatingsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About Medicine Man Technologies (OTCMKTS:SHWZ) StockMedicine Man Technologies, Inc. engages in the cultivation, manufacture, distribution, and retail sale of cannabis and cannabis related products. It operates through the following segments: Retail, Wholesale, and Other. The Retail segment includes retail locations for sale of cannabis products. The Wholesale segment manufactures, cultivates, and sells wholesale cannabis and non-cannabis products. The Other segment includes the general corporate operations not categorized as retail or wholesale, and revenue from in-store advertisements and certain vendor operations. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.Read More Receive SHWZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address SHWZ Stock News HeadlinesMay 31, 2023 | finanznachrichten.deMedicine Man Technologies, Inc.; Schwazze: MULTI-STATE CANNABIS OPERATOR, SCHWAZZE, PROMOTES NIRUP KRISHNAMURTHY TO CHIEF EXECUTIVE OFFICERMay 31, 2023 | finance.yahoo.comMULTI-STATE CANNABIS OPERATOR, SCHWAZZE, PROMOTES NIRUP KRISHNAMURTHY TO CHIEF EXECUTIVE OFFICERJune 5, 2023 | Edge On The Street (Ad)Investor Alert: EV Initiatives Create Unsustainable Demand For LithiumThe soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.May 16, 2023 | finance.yahoo.comMULTI-STATE CANNABIS OPERATOR, SCHWAZZE, ANNOUNCES GRAND REOPENING OF EMERALD FIELDS STORE IN DENVER, COLORADOMay 12, 2023 | finanznachrichten.deMedicine Man Technologies, Inc.; Schwazze: MULTI-STATE CANNABIS OPERATOR, SCHWAZZE, ACQUIRES TWO RETAIL DISPENSARIES FROM SMOKEY'S CANNABIS COMPANYMay 12, 2023 | finance.yahoo.comMULTI-STATE CANNABIS OPERATOR, SCHWAZZE, ACQUIRES TWO RETAIL DISPENSARIES FROM SMOKEY'S CANNABIS COMPANYMay 11, 2023 | finance.yahoo.comMedicine Man Technologies, Inc. (PNK:SHWZ) Q1 2023 Earnings Call TranscriptMay 11, 2023 | msn.comSchwazze Q1 FY23 Revenue Grows 26% YoY, What About Profit?June 5, 2023 | Edge On The Street (Ad)Investor Alert: EV Initiatives Create Unsustainable Demand For LithiumThe soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.May 10, 2023 | finanznachrichten.deMedicine Man Technologies, Inc.; Schwazze: SCHWAZZE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTSMay 10, 2023 | finance.yahoo.comSCHWAZZE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTSMay 3, 2023 | finance.yahoo.comSCHWAZZE ANNOUNCES FIRST QUARTER EARNINGS CALLMay 1, 2023 | finance.yahoo.comMULTI-STATE CANNABIS OPERATOR, SCHWAZZE, ANNOUNCES EXECUTIVE VICE PRESIDENT OF COMMERCIAL SALES, CHRIS DRIESSENApril 26, 2023 | markets.businessinsider.comNoble Financial Reaffirms Their Buy Rating on Medicine Man Technologies (SHWZ)April 25, 2023 | msn.comSchwazze To Expand Its Presence In New Mexico Via Acquisition Of EverestApril 25, 2023 | finance.yahoo.comSCHWAZZE SIGNS DEFINITIVE DOCUMENTS TO ACQUIRE ASSETS OF SUCELLUS, MANAGE ASSETS OF EVEREST, A PROMINENT NEW MEXICO CANNABIS OPERATORApril 18, 2023 | benzinga.comSchwazze To Acquire One Medical Cannabis Dispensary In Denver, ColoradoApril 18, 2023 | finance.yahoo.comSchwazze Signs Definitive Documents to Acquire One Medical Retail Dispensary in Denver, Colorado, from Standing AkimboApril 6, 2023 | finance.yahoo.comSCHWAZZE LAUNCHES EDW - A NEW READY-TO-ROLL, HALF OUNCE PRE-GROUND FLOWER PRODUCTApril 2, 2023 | americanbankingnews.comMedicine Man Technologies' (SHWZ) "Buy" Rating Reiterated at BenchmarkApril 1, 2023 | finance.yahoo.comMedicine Man Technologies, Inc. (PNK:SHWZ) Q4 2022 Earnings Call TranscriptMarch 31, 2023 | markets.businessinsider.comBTIG Remains a Buy on Medicine Man Technologies (SHWZ)March 29, 2023 | finance.yahoo.comSCHWAZZE ANNOUNCES FOURTH QUARTER 2022 & YEAR-END 2022 RESULTSMarch 27, 2023 | msn.comMovers & Shakers: NM Regulator Resigns & Other Key Executive Moves To Know AboutMarch 24, 2023 | finanznachrichten.deMedicine Man Technologies, Inc.; Schwazze: SCHWAZZE ANNOUNCES FOURTH QUARTER EARNINGS CALLMarch 22, 2023 | markets.businessinsider.comMedicine Man Technologies (SHWZ) Receives a Buy from Noble FinancialMarch 21, 2023 | finance.yahoo.comMULTI-STATE CANNABIS OPERATOR, SCHWAZZE, CONTINUES EXPANSION EFFORTS IN NEW MEXICO WITH ADDITIONAL R.GREENLEAF STORE IN CARLSBADSee More Headlines SHWZ Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHWZ Company Calendar Today6/05/2023Next Earnings (Estimated)8/09/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Consulting Services Sub-IndustryN/A SectorIndustrials Current SymbolOTCMKTS:SHWZ CUSIPN/A CIK1622879 Webwww.schwazze.com Phone(303) 371-0387FaxN/AEmployees389Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.00 High Stock Price Forecast$3.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+191.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesNirup KrishnamurthyChief Executive Officer & DirectorForrest HoffmasterChief Financial OfficerSteven T. LiedtkeVice President-Information ServicesEd EissenstatVice President-IT & CIOLee Alexander DaytonChief Administrative OfficerKey CompetitorsAllyMe GroupOTCMKTS:WWINALSOTCMKTS:CPBLFAmerican CannabisOTCMKTS:AMMJBureau VeritasOTCMKTS:BVVBYIntertek GroupOTCMKTS:IKTSFView All Competitors SHWZ Stock - Frequently Asked Questions Should I buy or sell Medicine Man Technologies stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medicine Man Technologies in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SHWZ shares. View SHWZ analyst ratings or view top-rated stocks. What is Medicine Man Technologies' stock price forecast for 2023? 2 equities research analysts have issued 12-month price objectives for Medicine Man Technologies' shares. Their SHWZ share price forecasts range from $3.00 to $3.00. On average, they anticipate the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 191.3% from the stock's current price. View analysts price targets for SHWZ or view top-rated stocks among Wall Street analysts. How have SHWZ shares performed in 2023? Medicine Man Technologies' stock was trading at $1.4157 at the beginning of 2023. Since then, SHWZ stock has decreased by 27.2% and is now trading at $1.03. View the best growth stocks for 2023 here. Are investors shorting Medicine Man Technologies? Medicine Man Technologies saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,900 shares, a decrease of 69.8% from the April 30th total of 6,300 shares. Based on an average trading volume of 78,500 shares, the short-interest ratio is presently 0.0 days. View Medicine Man Technologies' Short Interest. When is Medicine Man Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our SHWZ earnings forecast. What other stocks do shareholders of Medicine Man Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Charlotte's Web (CWBHF), GrowGeneration (GRWG), Harvest Health & Recreation (HRVSF), Trulieve Cannabis (TCNNF), Curaleaf (CURLF), ETFMG Alternative Harvest ETF (MJ), Organigram (OGI), Village Farms International (VFF) and Cresco Labs (CRLBF). What is Medicine Man Technologies' stock symbol? Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "SHWZ." How do I buy shares of Medicine Man Technologies? Shares of SHWZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Medicine Man Technologies' stock price today? One share of SHWZ stock can currently be purchased for approximately $1.03. How many employees does Medicine Man Technologies have? The company employs 389 workers across the globe. How can I contact Medicine Man Technologies? The official website for the company is www.schwazze.com. The company can be reached via phone at (303) 371-0387. This page (OTCMKTS:SHWZ) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicine Man Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.